End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
87.80 TWD | +1.15% | +0.34% | +17.85% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 448B | 447B | 474B | 525B | 581B | |||||
Total Revenues | 448B | 447B | 474B | 525B | 581B | |||||
Cost of Goods Sold, Total | 294B | 293B | 317B | 357B | 393B | |||||
Gross Profit | 154B | 154B | 156B | 168B | 188B | |||||
Selling General & Admin Expenses, Total | 123B | 123B | 127B | 138B | 158B | |||||
Provision for Bad Debts | 5.63M | 98.9M | 56.24M | 20.65M | 72.78M | |||||
R&D Expenses | 913M | 903M | 933M | 919M | 1.02B | |||||
Other Operating Expenses, Total | 124B | 124B | 128B | 139B | 159B | |||||
Operating Income | 29.63B | 29.78B | 28.39B | 29.02B | 28.64B | |||||
Interest Expense, Total | -2.57B | -2.44B | -2.08B | -2.49B | -3.49B | |||||
Interest And Investment Income | 2.6B | 2.58B | 1.93B | 2.93B | 4.97B | |||||
Net Interest Expenses | 33.29M | 137M | -159M | 430M | 1.48B | |||||
Income (Loss) On Equity Invest. | 3.1B | 3.86B | 3.96B | 2.06B | 2.57B | |||||
Currency Exchange Gains (Loss) | -12.55M | 68.61M | 74.74M | 101M | 120M | |||||
Other Non Operating Income (Expenses) | 3.73B | 4.24B | 3.71B | 3.57B | 3.33B | |||||
EBT, Excl. Unusual Items | 36.48B | 38.09B | 35.97B | 35.18B | 36.14B | |||||
Impairment of Goodwill | - | - | -21M | -289M | - | |||||
Gain (Loss) On Sale Of Investments | -99.42M | -14.18M | -157M | 3.98M | 10.91B | |||||
Gain (Loss) On Sale Of Assets | -60.93M | 275M | 152M | 175M | -69.02M | |||||
Asset Writedown | 8.9M | 6.57M | -86.31M | 14.24M | 311K | |||||
Other Unusual Items | 68.02M | 75.69M | 408M | 254M | 1.71B | |||||
EBT, Incl. Unusual Items | 36.4B | 38.44B | 36.27B | 35.34B | 48.69B | |||||
Income Tax Expense | 7.91B | 7.64B | 7.47B | 8.82B | 18.4B | |||||
Earnings From Continuing Operations | 28.48B | 30.8B | 28.8B | 26.53B | 30.29B | |||||
Net Income to Company | 28.48B | 30.8B | 28.8B | 26.53B | 30.29B | |||||
Minority Interest | -9.48B | -9.26B | -8.92B | -9.36B | -11.95B | |||||
Net Income - (IS) | 19.01B | 21.54B | 19.88B | 17.17B | 18.34B | |||||
Net Income to Common Incl Extra Items | 19.01B | 21.54B | 19.88B | 17.17B | 18.34B | |||||
Net Income to Common Excl. Extra Items | 19.01B | 21.54B | 19.88B | 17.17B | 18.34B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.35 | 3.79 | 3.5 | 3.02 | 3.23 | |||||
Basic EPS - Continuing Operations | 3.35 | 3.79 | 3.5 | 3.02 | 3.23 | |||||
Basic Weighted Average Shares Outstanding | 5.68B | 5.68B | 5.68B | 5.68B | 5.68B | |||||
Net EPS - Diluted | 3.33 | 3.77 | 3.48 | 3.01 | 3.21 | |||||
Diluted EPS - Continuing Operations | 3.33 | 3.77 | 3.48 | 3.01 | 3.21 | |||||
Diluted Weighted Average Shares Outstanding | 5.71B | 5.72B | 5.71B | 5.71B | 5.71B | |||||
Normalized Basic EPS | 2.34 | 2.56 | 2.39 | 2.22 | 1.87 | |||||
Normalized Diluted EPS | 2.33 | 2.55 | 2.37 | 2.21 | 1.86 | |||||
Dividend Per Share | 2.5 | 2.7 | 2.7 | 3.15 | 3 | |||||
Payout Ratio | 74.73 | 65.94 | 77.18 | 89.36 | 97.64 | |||||
American Depositary Receipts Ratio (ADR) | 10 | 10 | 10 | 10 | 10 | |||||
Supplemental Items | ||||||||||
EBITDA | 48.99B | 48.87B | 47.46B | 48.15B | 49.63B | |||||
EBITA | 30.22B | 30.41B | 29.01B | 29.61B | 29.38B | |||||
EBIT | 29.63B | 29.78B | 28.39B | 29.02B | 28.64B | |||||
EBITDAR | 50.67B | 50.34B | 49.02B | 49.62B | 51.43B | |||||
Effective Tax Rate - (Ratio) | 21.74 | 19.87 | 20.6 | 24.94 | 37.8 | |||||
Total Current Taxes | 7.85B | 7.56B | 7.71B | 7.78B | 8.23B | |||||
Total Deferred Taxes | 62.42M | 75.19M | -240M | 1.04B | 10.17B | |||||
Normalized Net Income | 13.32B | 14.55B | 13.56B | 12.63B | 10.64B | |||||
Interest Capitalized | 51.94M | 5.26M | 8.72M | 13.12M | 17.76M | |||||
Interest on Long-Term Debt | 1.12B | 1.17B | 1.07B | 1.05B | 1.47B | |||||
Non-Cash Pension Expense | 73.88M | 74.8M | 43.76M | 55.75M | 70.82M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 102B | 102B | 105B | 115B | 132B | |||||
General and Administrative Expenses | 21.28B | 21.66B | 21.6B | 22.8B | 25.82B | |||||
Research And Development Expense From Footnotes | 913M | 1.02B | 1.04B | 1.02B | 1.13B | |||||
Net Rental Expense, Total | 1.67B | 1.47B | 1.57B | 1.47B | 1.81B | |||||
Imputed Operating Lease Interest Expense | 260M | 169M | 148M | 153M | 214M | |||||
Imputed Operating Lease Depreciation | 1.41B | 1.3B | 1.42B | 1.32B | 1.59B |